Clinical trial
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus…
NCT00423891 · Bristol-Myers Squibb, Industry · Completed
Key facts
| NCT number | NCT00423891 |
|---|---|
| Title | A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection |
| Official title | Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive |
| Lead sponsor | Bristol-Myers Squibb, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis B, Chronic |
| Intervention type | Drug |
| Interventions | Entecavir |
| Enrollment | 64 |
| Start date | Jun 30, 2007 |
| Primary completion | Aug 31, 2013 |
| Completion | Sep 4, 2017 |
| First posted | Jan 18, 2007 |
| Last update posted | May 2, 2018 |
| Countries | Argentina, Belgium, Brazil, Canada, South Korea, Taiwan, United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: